-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Zinpentraxin Alfa in Crohn’s Disease (Regional Enteritis)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Zinpentraxin Alfa in Crohn's Disease (Regional Enteritis) Drug Details:Zinpentraxin alfa (PRM-151) is under development for the...
-
Product Insights
Harris FCD – Countywide Stormwater Conveyance Tunnels – Texas
Equip yourself with the essential tools needed to make informed and profitable decisions with our Harris FCD - Countywide Stormwater Conveyance Tunnels - Texas report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Net Present Value Model: Zinpentraxin alfa
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Zinpentraxin alfa Drug Details Zinpentraxin alfa...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – zinpentraxin alfa
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry zinpentraxin alfa Drug Details Zinpentraxin alfa (PRM-151) is under development for the treatment of...
-
Sector Analysis
KOL Perspectives: Fistulising Crohn’s disease
› This KOL Insight briefing focuses on fistulizing Crohn’s disease (FCD)